Nerdwallet Inc (NRDS) concluded trading on Wednesday at a closing price of $14.33, with 0.31 million shares of worth about $4.51 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.70% during that period and on January 08, 2025 the price saw a loss of about -0.35%. Currently the company’s common shares owned by public are about 42.34M shares, out of which, 33.86M shares are available for trading.
Stock saw a price change of 7.74% in past 5 days and over the past one month there was a price change of 5.91%. Year-to-date (YTD), NRDS shares are showing a performance of 7.74% which increased to 3.32% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.10 but also hit the highest price of $17.30 during that period. The average intraday trading volume for Nerdwallet Inc shares is 687.23K. The stock is currently trading 6.27% above its 20-day simple moving average (SMA20), while that difference is up 2.98% for SMA50 and it goes to 6.39% higher than SMA200.
Nerdwallet Inc (NASDAQ: NRDS) currently have 42.34M outstanding shares and institutions hold larger chunk of about 36.83% of that.
The stock has a current market capitalization of $1.05B and its 3Y-monthly beta is at 1.32. It has posted earnings per share of -$0.14 in the same period. It has Quick Ratio of 2.91 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NRDS, volatility over the week remained 3.79% while standing at 4.14% over the month.
Stock’s fiscal year EPS is expected to rise by 35.56% while it is estimated to increase by 484.48% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on May 03, 2023 offering a Neutral rating for the stock and assigned a target price range of between $15 and $14 to it. On November 29, 2021, Truist Initiated their recommendations, while on November 29, 2021, Oppenheimer Initiated their ratings for the stock with a price target of $30. Stock get an Equal-weight rating from Morgan Stanley on November 29, 2021.
